"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
- Patient Information:
Details with Side Effects
How to Use The DROP-TAINER®*Bottle
The DROP-TAINER® bottle is designed to assure the delivery of a precise dose of medication. Before using your DROP-TAINER® bottle, read the complete instructions carefully.
- If you use other topically applied ophthalmic medications, they should be administered at least 10 minutes before BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) .
- Wash hands before each use.
- Before using the medication for the first time, be sure the Safety Seal on the bottle is unbroken.
- Tear off the Safety Seal to break the seal.
- Before each use, shake well and remove the screw cap.
- Invert the bottle and hold the bottle between your thumb and middle finger, with the tips of the fingers pointing towards you.
- Tilt your head back and position the bottle above the affected eye. DO NOT TOUCH THE EYE WITH THE TIP OF THE DROPPER.
- With the opposite hand, place a finger under the eye. Gently pull down until a "V" pocket is made between your eye and lower lid.
- With the hand holding the bottle, place your index finger on the bottom of the bottle. Push the bottom of the bottle to dispense one drop of medication. DO NOT SQUEEZE THE SIDES OF THE BOTTLE.
- Repeat 6, 7, 8, and 9 with other eye if instructed to do so. 11. Replace screw cap by turning until firmly touching the bottle.
Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye(s) or surrounding structures. Patients should also be instructed that ocular solutions, if handled improperly, could become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye(s) and subsequent loss of vision may result from using contaminated solutions. physician's present multidose container.
Patients requiring concomitant topical ophthalmic medications should be instructed to administer these at least 10 minutes before instilling BETOPTIC S® (betaxolol hydrochloride ophthalmic suspension) Suspension.
Last reviewed on RxList: 7/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Betoptic S Information
Betoptic S - User Reviews
Betoptic S User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.